Trial intelligence / Profile preview

Tenoxicam vs Triamcinolone in Knee Osteoarthritis

NCT07194135Completed

Sponsor
Benha University
Start
Nov 2024
Primary completion
Apr 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of tenoxicam in osteoarthritis (OA) (2 arms), sponsored by Benha University. Primary endpoint: Change in Knee Pain Intensity Measured by Visual Analog Scale at 12 weeks. Started Nov 2024; status: completed.

02

Drugs

tenoxicam
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT07194135.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07194135.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call